UBS O'Connor’s Arbor Rapha Capital Bioholdings Corp. I Units ARCKU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-412,616
Closed -$4.18M 609
2021
Q4
$4.18M Buy
+412,616
New +$4.17M 0.04% 327

Other funds holding ARCKU

UBS O'Connor's ARCKU Position: Q1 2022 in Review

UBS O'Connor sold out of Arbor Rapha Capital Bioholdings Corp. I Units (ARCKU) in Q1 2022, closing a stake of 412,616 shares — an estimated $4.18M sold.

UBS O'Connor first reported a position in ARCKU in Q4 2021 and held it in 1 quarter. The position peaked at $4.18M in Q4 2021. 23 funds tracked by Wall St. Rank hold ARCKU as of Q1 2022.

  • UBS O'Connor reported no remaining Arbor Rapha Capital Bioholdings Corp. I Units position as of Q1 2022 after selling out during the quarter.
  • UBS O'Connor sold 412,616 Arbor Rapha Capital Bioholdings Corp. I Units shares in Q1 2022, an estimated $4.18M.
  • UBS O'Connor first reported a position in Arbor Rapha Capital Bioholdings Corp. I Units in Q4 2021 and held it in 1 quarter.
  • UBS O'Connor's Arbor Rapha Capital Bioholdings Corp. I Units position peaked at $4.18M in Q4 2021.
  • 23 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Units as of Q1 2022.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.